ADVAXIS, INC. Chart calendar Advaxis, Inc.
0e6.YlEGTyRnlmkl_e_HB-gnAUk2g27GxWcqI3T2DzJnBns.BClIYkUd7DZDtpnxX44QUR140Qr2lgleREejbmsjbhc7Nk8hRxHGPWGSmA~1e7d94c5755272227d15e031521743d5
Upcoming events on Advaxis, Inc.
No events available
Past events on Advaxis, Inc.
| 2023-10-19 | European Society for Medical Oncology Congress |
| 2023-08-10 04:30 pm | Q2 2023 Earnings Release |
| 2023-07-27 | Annual General Meeting |
| 2023-01-12 | Extraordinary Shareholders Meeting |
| 2022-09-12 06:40 pm | Q3 2022 Earnings Release |
| 2022-06-28 10:00 am | Annual General Meeting |
| 2022-06-08 08:00 am | Interim 2022 Earnings Release |
| 2022-06-06 02:15 pm | American Society of Clinical Oncology Meeting - Abstract Number: TPS5115 |
| 2022-06-06 09:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 9038 |
| 2022-06-06 09:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 9042 |
| 2022-06-05 | Reverse Split: 1 of 80 |
| 2022-03-31 10:00 am | Extraordinary Shareholders Meeting |
| 2022-03-17 09:00 am | Q1 2022 Earnings Release |
| 2022-02-13 | FY 2021 Earnings Release |
| 2022-01-04 | LifeSci Partners Corporate Access Event |
| 2021-12-15 | Extraordinary Shareholders Meeting - Second Call |
| 2021-12-07 10:00 am | Extraordinary Shareholders Meeting - M&A Vote |
| 2021-09-10 08:30 am | Q3 2021 Earnings Release |
| 2021-07-06 08:30 am | Advaxis, Inc and Biosight Ltd Merger Call |
| 2021-06-14 04:05 pm | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2023 |
|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,01 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - |
|
EBIT | Released Forecast Spread | 0,00 0,00 - |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - |
|
Net income | Released Forecast Spread | 0,00 0,00 - |
|
EPS | Released Forecast Spread | 0,00 0,00 - |
| Announcement Date | 16/04/24 |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
